GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MRSN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Mersana Therapeutics, Inc. stock after losing 2.69%
(Updated on Apr 19, 2024)

Sell candidate since Mar 25, 2024 Loss -23.89% PDF

The Mersana Therapeutics, Inc. stock price fell by -2.69% on the last day (Friday, 19th Apr 2024) from $3.34 to $3.25. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 5.35% from a day low at $3.18 to a day high of $3.35. The price has fallen in 8 of the last 10 days and is down by -24.07% for this period. Volume has increased on the last day by 1 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $7.66 million.

Given the current short-term trend, the stock is expected to rise 15.53% during the next 3 months and, with a 90% probability hold a price between $3.75 and $7.41 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

MRSN Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Mersana Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.60 and $4.64. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 01, 2024, and so far it has fallen -45.29%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Mersana Therapeutics, Inc. stock

Mersana Therapeutics, Inc. finds support from accumulated volume at $3.13 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.170 between high and low, or 5.35%. For the last week, the stock has had daily average volatility of 6.87%.

Mersana Therapeutics, Inc. is oversold on RSI14 (19). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MRSN) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Mersana Therapeutics, Inc. to open at $3.26, and during the day (based on 14 day Average True Range), to move between $2.93 and $3.57, which gives a possible trading interval of +/-$0.315 (+/-9.69%) up or down from last closing price. If Mersana Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 19.39% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.13 (3.69%) than the resistance at $3.79 (16.62%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Mersana Therapeutics, Inc. stock A Buy?

The Mersana Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Mersana Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.928 Sell Candidate Unchanged

Predicted Opening Price for Mersana Therapeutics, Inc. of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$3.26 ( 0.308%) $3.25

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MRSN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.43 5.54 %
R2 3.37 3.54 %
R1 3.32 2.31 %
Current price: 3.25
Support S1 3.20 -1.69 %
S2 3.15 -2.92 %
S3 3.09 -4.92 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.88 19.38 %
R2 3.84 18.15 %
R1 3.79 16.62 %
Current price 3.25
Support S1 3.13 -3.69%
S2 3.10 -4.62%
S3 2.82 -13.23%

FAQ

What is the symbol for Mersana Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Mersana Therapeutics, Inc. is MRSN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Mersana Therapeutics, Inc. Stock?
The Mersana Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Mersana Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Mersana Therapeutics, Inc. Stock?
Mersana Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Mersana Therapeutics, Inc. Stock.

What's the current price of Mersana Therapeutics, Inc. Stock?
As of the end of day on the 2024-04-19, the price of an Mersana Therapeutics, Inc. (MRSN) share was $3.25.

What is the 52-week high and low for Mersana Therapeutics, Inc. Stock?
The 52-week high for Mersana Therapeutics, Inc. Stock is $9.62 and the 52-week low is $0.80.

What is the market capitalization of Mersana Therapeutics, Inc. Stock?
As of the 2024-04-19, the market capitalization of Mersana Therapeutics, Inc. is 391.892M.

When is the next earnings date for Mersana Therapeutics, Inc.?
The upcoming earnings date for Mersana Therapeutics, Inc. is May 07, 2024.
Click to get the best stock tips daily for free!

About Mersana Therapeutics, Inc.

Mersana Therapeutics. Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also develops XMT-1660, a B7-H4-targeted Dolasynthen ADC candidate; and XMT-2056, an immunosynthen development ... MRSN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT